Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Radiotherapy With GM-CSF in Advanced Solid Tumors
NCT00091052Phase 2Completed
- Sponsor
- Sirius Group
- Start
- Jul 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in solid tumor, sponsored by Sirius Group. Started Jul 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00091052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091052.